Management 2 has entered full manufacturing at Treatment Leisure, which implies growth on the sequel to the studio’s beloved 2019 action-adventure hit is now formally in full swing. Not lengthy earlier than coming into this stage of manufacturing, in November final yr, Treatment revealed that Management 2 was being developed on a funds of €50 million, and now, the studio has shed extra gentle on that entrance.
Curiously sufficient, Management 2 is being developed on a smaller funds than Alan Wake 2. Talking with Sport File, Treatment CEO Tero Virtala revealed that the 2023 survival horror title’s funds was really “a bit larger” than what Treatment has earmarked for Management 2. “I feel with that we will create wonderful video games,” Virtala mentioned, and added {that a} recreation constructed on that funds would be capable to break even even at 2 million copies bought.
“That then builds the idea that, if we create a superb recreation and it occurs to promote 4 million or 5 million models, then we’re actually blissful,” he continued.
In February, Treatment Leisure introduced that Alan Wake 2 had bought over 2 million models, recouping growth and advertising and marketing prices.
Ballooning growth budgets have been an more and more worrying subject for the video games business over current years, and it’s truthful to say that they’ve been a significant component in widespread business issues, from studio closures to mass layoffs. In that context, Treatment selecting to construct on the success of its final main launch by constructing its subsequent massive recreation on a smaller growth funds, and never as an alternative succumbing to the need to purpose for greater and higher in each approach potential, is definitely a refreshing change of tempo.
